Clinical Research Medical Research Pharmacology Oncology Cell Biology Immunology Patient Care Public Health Clinical Trials Pharmaceuticals
It leverages CRISPR/Cas9 disruption of the interferon-γ receptor to boost CAR-T cell durability ahead of planned solid tumor trials.